In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse

Domokos Máthé, Ildikó Horváth, Krisztián Szigeti, Sean R. Donohue, Victor W. Pike, Zisheng Jia, Catherine Ledent, Miklós Palkovits, Tamás F. Freund, Christer Halldin, Balázs Gulyás

Research output: Contribution to journalArticle

1 Citation (Scopus)


We aimed to evaluate the novel high-affinity and relatively lipophilic CB1 receptor (CB1R) antagonist radioligand [125I]SD7015 for SPECT imaging of CB1Rs in vivo using the multiplexed multipinhole dedicated small animal SPECT/CT system, NanoSPECT/CTPLUS (Mediso, Budapest, Hungary), in knock-out CB1 receptor knock-out (CB1R-/-) and wildtype mice. In order to exclude possible differences in cerebral blood flow between the two types of animals, HMPAO SPECT scans were performed, whereas in order to confirm the brain uptake differences of the radioligand between knock-out mice and wildtype mice, in vivo scans were complemented with ex vivo autoradiographic measurements using the brains of the same animals. With SPECT/CT imaging, we measured the brain uptake of radioactivity, using %SUV (% standardised uptake values) in CB1R-/- mice (n=3) and C57BL6 wildtype mice (n=7) under urethane anaesthesia after injecting [125I]SD7015 intravenously or intraperitoneally. The Brookhaven Laboratory mouse MRI atlas was fused to the SPECT/CT images by using a combination of rigid and non-rigid algorithms in the Mediso Fusion™ (Mediso, Budapest, Hungary) and VivoQuant (inviCRO, Boston, MA, USA) softwares. Phosphor imager plate autoradiography (ARG) was performed on 4μm-thin cryostat sections of the excised brains. %SUV was 8.6±3.6 (average±SD) in CB1R-/- mice and 22.1±12.4 in wildtype mice between 2 and 4h after injection (p<0.05). ARG of identically taken sections from wildtype mouse brain showed moderate radioactivity uptake when compared with the in vivo images, with a clear difference between grey matter and white matter, whereas ARG in CB1R(-/-) mice showed practically no radioactivity uptake. [125I]SD7015 enters the mouse brain in sufficient amount to enable SPECT imaging. Brain radioactivity distribution largely coincides with that of the known CB1R expression pattern in rodent brain. We conclude that [125I]SD7015 should be a useful SPECT radioligand for studying brain CB1R in mouse and rat disease models.

Original languageEnglish
Pages (from-to)46-51
Number of pages6
JournalBrain Research Bulletin
Publication statusPublished - Feb 1 2013


  • Endocannabinoid CB receptor (CBR)
  • Knock-out CBR-/- mouse
  • Molecular imaging biomarker
  • Multiplexed multipinhole dedicated small animal SPECT/CT system
  • Single photon emission computed tomography (SPECT)
  • [I]SD7015

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB<sub>1</sub> receptor antagonist radioligand [<sup>125</sup>I]SD7015 in CB<sub>1</sub> knock-out and wildtype mouse'. Together they form a unique fingerprint.

  • Cite this